Resources Informative Resources Take a look at the latest on Palatin across our media publications, posters, and presentations. Choose Indication All Indications Cardiovascular (4) Female Sexual Dysfunction (34) Inflammatory and Autoimmune (9) Obesity and Diabetes (8) Ocular (18) Choose Resource Type All Resources Abstract (1) Infographic (1) Poster (49) Presentation (6) Publication (15) Webcast (4) Search Resources Characterization of the Melanocortin Receptor 4 Oral Small Molecule Agonist PL7737 2025-November Co-Administration of Bremelanotide With Tirzepatide in Participants With Obesity 2025-November Activating the Melanocortin System Resolves Inflammation, Reduces VEGF Signaling in Diabetic Retinopathy (DR), and Provides Retinal Ganglion Cell (RGC) Protection 2025-May Efficacy and Safety of PL9643 in Dry Eye Disease: Results From a Phase 3, Randomized, Vehicle-Controlled Study 2025-May Activation of the Melanocortin System Increases Aqueous Outflow, Reduces Intraocular Pressure (IOP), and Protects Neurons in Glaucoma Models 2025-May Efficacy of Bremelanotide (BMT) to Stabilize Podocyte Function and Reduce Proteinuria in Adults with Type II Diabetic Nephropathy: Results from a Phase IIb, Open-Label Study 2025-April Melanocortin Agonist PL7737 Causes Weight Loss and Decreases Food Consumption in Obese Mice 2024-November Harnessing the Melanocortin System to Heal Inflammatory Diseases 2024-October Structural Modifications Allow the Removal of Melanocortin Receptor 1 Agonism From Melanocortin Receptor 4 Agonists 2024-October Virtual KOL Event: Beyond GLPs: The Multiple Roles for Novel Melanocortin Receptor 4 Agonists in Treating Obesity and Weight Loss Maintenance 2024-May
